These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
652 related articles for article (PubMed ID: 33212091)
1. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity. Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091 [TBL] [Abstract][Full Text] [Related]
2. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay. Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532 [TBL] [Abstract][Full Text] [Related]
3. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes. Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP Front Immunol; 2023; 14():1225047. PubMed ID: 37822938 [TBL] [Abstract][Full Text] [Related]
4. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591 [TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion. Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852 [TBL] [Abstract][Full Text] [Related]
6. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes. Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202 [TBL] [Abstract][Full Text] [Related]
7. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire. Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149 [TBL] [Abstract][Full Text] [Related]
8. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients. Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608 [TBL] [Abstract][Full Text] [Related]
9. Cryopreservation of peripheral blood mononuclear cells for use in proliferation assays: First step towards potency assays. Juhl M; Christensen JP; Pedersen AE; Kastrup J; Ekblond A J Immunol Methods; 2021 Jan; 488():112897. PubMed ID: 33049298 [TBL] [Abstract][Full Text] [Related]
10. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing. Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362 [TBL] [Abstract][Full Text] [Related]
11. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs. Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis. Zhang Z; Ding Y; Li W; Song B; Yang R Arthritis Res Ther; 2013 Oct; 15(5):R169. PubMed ID: 24286220 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1). Nicotra T; Desnos A; Halimi J; Antonot H; Reppel L; Belmas T; Freton A; Stranieri F; Mebarki M; Larghero J; Cras A; Faivre L Stem Cell Res Ther; 2020 Oct; 11(1):426. PubMed ID: 33004063 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation. Mousavi Niri N; Jaberipour M; Razmkhah M; Ghaderi A; Habibagahi M Iran J Immunol; 2009 Dec; 6(4):186-94. PubMed ID: 20054106 [TBL] [Abstract][Full Text] [Related]
15. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro. Mckinnirey F; Herbert B; Vesey G; McCracken S Sci Rep; 2021 Jun; 11(1):12454. PubMed ID: 34127731 [TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Zhou C; Yang B; Tian Y; Jiao H; Zheng W; Wang J; Guan F Cell Immunol; 2011; 272(1):33-8. PubMed ID: 22004796 [TBL] [Abstract][Full Text] [Related]
18. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease. Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861 [TBL] [Abstract][Full Text] [Related]
19. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells. Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy. Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]